Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QG76
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016310 | phosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004672 | protein kinase activity | 3 | 12 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 2 |
GO:0004707 | MAP kinase activity | 5 | 2 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016301 | kinase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 174 | 178 | PF00656 | 0.515 |
CLV_C14_Caspase3-7 | 338 | 342 | PF00656 | 0.378 |
CLV_C14_Caspase3-7 | 57 | 61 | PF00656 | 0.466 |
CLV_NRD_NRD_1 | 195 | 197 | PF00675 | 0.583 |
CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.449 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 195 | 197 | PF00082 | 0.557 |
CLV_PCSK_KEX2_1 | 511 | 513 | PF00082 | 0.629 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.494 |
CLV_PCSK_PC1ET2_1 | 511 | 513 | PF00082 | 0.635 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 301 | 305 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 388 | 392 | PF00082 | 0.344 |
CLV_PCSK_SKI1_1 | 429 | 433 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 438 | 442 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 528 | 532 | PF00082 | 0.423 |
DEG_APCC_DBOX_1 | 527 | 535 | PF00400 | 0.424 |
DEG_COP1_1 | 507 | 516 | PF00400 | 0.623 |
DEG_ODPH_VHL_1 | 186 | 199 | PF01847 | 0.507 |
DEG_SPOP_SBC_1 | 211 | 215 | PF00917 | 0.518 |
DOC_CYCLIN_RxL_1 | 385 | 395 | PF00134 | 0.385 |
DOC_CYCLIN_RxL_1 | 98 | 105 | PF00134 | 0.407 |
DOC_MAPK_gen_1 | 18 | 24 | PF00069 | 0.482 |
DOC_MAPK_gen_1 | 301 | 310 | PF00069 | 0.344 |
DOC_MAPK_RevD_3 | 5 | 19 | PF00069 | 0.587 |
DOC_PP4_FxxP_1 | 136 | 139 | PF00568 | 0.405 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.513 |
DOC_USP7_MATH_1 | 270 | 274 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 412 | 416 | PF00917 | 0.434 |
DOC_USP7_UBL2_3 | 437 | 441 | PF12436 | 0.427 |
DOC_WW_Pin1_4 | 213 | 218 | PF00397 | 0.662 |
DOC_WW_Pin1_4 | 356 | 361 | PF00397 | 0.417 |
DOC_WW_Pin1_4 | 447 | 452 | PF00397 | 0.407 |
DOC_WW_Pin1_4 | 456 | 461 | PF00397 | 0.312 |
LIG_14-3-3_CanoR_1 | 212 | 217 | PF00244 | 0.521 |
LIG_Actin_WH2_2 | 157 | 175 | PF00022 | 0.411 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.647 |
LIG_BIR_III_1 | 1 | 5 | PF00653 | 0.615 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.615 |
LIG_EH_1 | 491 | 495 | PF12763 | 0.398 |
LIG_eIF4E_1 | 89 | 95 | PF01652 | 0.514 |
LIG_FHA_1 | 114 | 120 | PF00498 | 0.415 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.557 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.580 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.510 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.442 |
LIG_FHA_1 | 350 | 356 | PF00498 | 0.363 |
LIG_FHA_1 | 426 | 432 | PF00498 | 0.385 |
LIG_FHA_1 | 448 | 454 | PF00498 | 0.420 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.469 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.418 |
LIG_FHA_2 | 180 | 186 | PF00498 | 0.508 |
LIG_FHA_2 | 336 | 342 | PF00498 | 0.375 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.587 |
LIG_LIR_Apic_2 | 134 | 139 | PF02991 | 0.413 |
LIG_LIR_Apic_2 | 344 | 350 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 147 | 154 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 159 | 170 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 544 | 551 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 147 | 151 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 157 | 161 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 275 | 281 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 367 | 372 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 39 | 44 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 404 | 409 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 498 | 503 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 51 | 55 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 544 | 549 | PF02991 | 0.544 |
LIG_LRP6_Inhibitor_1 | 431 | 437 | PF00058 | 0.320 |
LIG_NRBOX | 33 | 39 | PF00104 | 0.541 |
LIG_PTB_Apo_2 | 489 | 496 | PF02174 | 0.399 |
LIG_REV1ctd_RIR_1 | 492 | 501 | PF16727 | 0.574 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.538 |
LIG_SH2_CRK | 500 | 504 | PF00017 | 0.548 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.436 |
LIG_SH2_NCK_1 | 347 | 351 | PF00017 | 0.363 |
LIG_SH2_NCK_1 | 41 | 45 | PF00017 | 0.518 |
LIG_SH2_NCK_1 | 75 | 79 | PF00017 | 0.547 |
LIG_SH2_SRC | 500 | 503 | PF00017 | 0.544 |
LIG_SH2_SRC | 75 | 78 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 148 | 152 | PF00017 | 0.526 |
LIG_SH2_STAP1 | 190 | 194 | PF00017 | 0.519 |
LIG_SH2_STAP1 | 392 | 396 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 335 | 338 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 392 | 395 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.524 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.629 |
LIG_SH3_3 | 500 | 506 | PF00018 | 0.535 |
LIG_SUMO_SIM_par_1 | 267 | 273 | PF11976 | 0.647 |
LIG_SUMO_SIM_par_1 | 351 | 359 | PF11976 | 0.449 |
LIG_TRAF2_1 | 71 | 74 | PF00917 | 0.545 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.568 |
LIG_TYR_ITIM | 290 | 295 | PF00017 | 0.381 |
MOD_CK1_1 | 213 | 219 | PF00069 | 0.678 |
MOD_CK1_1 | 313 | 319 | PF00069 | 0.443 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.416 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.510 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.464 |
MOD_CK2_1 | 412 | 418 | PF00069 | 0.431 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.546 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.413 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.695 |
MOD_GlcNHglycan | 411 | 415 | PF01048 | 0.418 |
MOD_GlcNHglycan | 525 | 528 | PF01048 | 0.525 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.431 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.494 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.718 |
MOD_GSK3_1 | 397 | 404 | PF00069 | 0.443 |
MOD_GSK3_1 | 412 | 419 | PF00069 | 0.447 |
MOD_GSK3_1 | 443 | 450 | PF00069 | 0.421 |
MOD_GSK3_1 | 519 | 526 | PF00069 | 0.563 |
MOD_N-GLC_1 | 240 | 245 | PF02516 | 0.673 |
MOD_N-GLC_1 | 329 | 334 | PF02516 | 0.475 |
MOD_N-GLC_1 | 341 | 346 | PF02516 | 0.191 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.400 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.441 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.449 |
MOD_NEK2_1 | 390 | 395 | PF00069 | 0.369 |
MOD_NEK2_1 | 432 | 437 | PF00069 | 0.386 |
MOD_NEK2_1 | 545 | 550 | PF00069 | 0.501 |
MOD_PIKK_1 | 341 | 347 | PF00454 | 0.363 |
MOD_PIKK_1 | 397 | 403 | PF00454 | 0.439 |
MOD_PK_1 | 512 | 518 | PF00069 | 0.620 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.753 |
MOD_PKA_2 | 316 | 322 | PF00069 | 0.449 |
MOD_PKA_2 | 482 | 488 | PF00069 | 0.326 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.416 |
MOD_Plk_1 | 176 | 182 | PF00069 | 0.480 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.586 |
MOD_Plk_1 | 310 | 316 | PF00069 | 0.449 |
MOD_Plk_1 | 341 | 347 | PF00069 | 0.369 |
MOD_Plk_1 | 76 | 82 | PF00069 | 0.594 |
MOD_Plk_2-3 | 144 | 150 | PF00069 | 0.474 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.478 |
MOD_Plk_4 | 176 | 182 | PF00069 | 0.490 |
MOD_Plk_4 | 189 | 195 | PF00069 | 0.514 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.348 |
MOD_Plk_4 | 401 | 407 | PF00069 | 0.389 |
MOD_Plk_4 | 545 | 551 | PF00069 | 0.519 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.605 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.473 |
MOD_ProDKin_1 | 213 | 219 | PF00069 | 0.662 |
MOD_ProDKin_1 | 356 | 362 | PF00069 | 0.417 |
MOD_ProDKin_1 | 447 | 453 | PF00069 | 0.407 |
MOD_ProDKin_1 | 456 | 462 | PF00069 | 0.312 |
MOD_SUMO_for_1 | 303 | 306 | PF00179 | 0.385 |
MOD_SUMO_for_1 | 551 | 554 | PF00179 | 0.593 |
MOD_SUMO_rev_2 | 537 | 545 | PF00179 | 0.523 |
MOD_SUMO_rev_2 | 554 | 559 | PF00179 | 0.525 |
TRG_DiLeu_BaEn_1 | 33 | 38 | PF01217 | 0.510 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.297 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.145 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.439 |
TRG_ENDOCYTIC_2 | 500 | 503 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.398 |
TRG_ER_diArg_1 | 194 | 196 | PF00400 | 0.590 |
TRG_ER_FFAT_1 | 73 | 81 | PF00635 | 0.509 |
TRG_Pf-PMV_PEXEL_1 | 101 | 105 | PF00026 | 0.404 |
TRG_Pf-PMV_PEXEL_1 | 301 | 306 | PF00026 | 0.413 |
TRG_Pf-PMV_PEXEL_1 | 407 | 411 | PF00026 | 0.434 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZJ0 | Leptomonas seymouri | 73% | 98% |
A0A0S4ILC2 | Bodo saltans | 23% | 100% |
A0A0S4JGZ1 | Bodo saltans | 25% | 100% |
A0A1X0NPK9 | Trypanosomatidae | 53% | 100% |
A0A3Q8I9M4 | Leishmania donovani | 88% | 92% |
A0A3S5IR55 | Trypanosoma rangeli | 53% | 100% |
A4H767 | Leishmania braziliensis | 79% | 92% |
A4HVK6 | Leishmania infantum | 89% | 79% |
E9APA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 98% |
V5AVM7 | Trypanosoma cruzi | 50% | 100% |